Rapid Diagnostic Tests Should Be Used To Screen Patients For Ebola

New York Times: Letter to the Editor: Testing for Ebola
Ranus S. Dhillon, internist and health systems/policy specialist in developing countries; Devabhaktuni Srikrishna, founder of Patient Knowhow; and Robert F. Garry, professor of microbiology and immunology at Tulane University and member of the Viral Hemorrhagic Fever Consortium

“…Rapid tests should have been used to screen patients [during the Ebola outbreak in West Africa], with all who test positive sent for confirmatory testing by polymerase chain reaction (PCR), the conventional test for Ebola, to minimize the possibility of false positives. … [I]n one study, rapid tests did not miss a single patient with actual Ebola, and only about eight percent were false positives. Rapid tests would have been a game-changer during the peak of the epidemic and should now be used to screen patients” (2/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.